Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

JWCTF

JW (Cayman) Therapeutics Co. Ltd

USD

Set alert

Price alert · JWCTF

All alert types
0.20 USD 0.00 0.00%
As of Oct 29, 2026
0.3364 Day range 0.3551
0.2022 52-week range 0.4523
YTD
-43.82%
1 year
-55.29%
Open
0.3368
Prev close
0.20223
Mkt cap
84.28M
Vol
55.50K
Avg vol
0
EPS
-0.12
P/E
0.00
More statistics
Low
0.3364
High
0.3551

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for JWCTF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-10.01 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 4

Valuation

P/E -1.9×
FY 2018: -4.7×FY 2019: -9.0×FY 2020: -1.5×FY 2021: -7.2×FY 2022: -1.7×FY 2023: -1.0×FY 2024: -0.8×FY 2025: -1.9×
FY 2018 5y median -1.7× FY 2025
P/S 3.8×
FY 2018: 34284×FY 2019: 1040×FY 2020: 0.0×FY 2021: 164×FY 2022: 9.8×FY 2023: 4.5×FY 2024: 3.1×FY 2025: 3.8×
FY 2018 5y median 4.5× FY 2025
P/B 1.9×
FY 2018: -23.5×FY 2019: -6.1×FY 2020: 0.7×FY 2021: 1.8×FY 2022: 0.6×FY 2023: 0.5×FY 2024: 0.4×FY 2025: 1.9×
FY 2018 5y median 0.6× FY 2025
P/FCF -13.3×
FY 2018: -49.0×FY 2019: -19.6×FY 2020: -6.4×FY 2021: -8.0×FY 2022: -2.3×FY 2023: -1.9×FY 2024: -1.4×FY 2025: -13.3×
FY 2018 5y median -2.3× FY 2025
EV/EBITDA -5.0×
FY 2018: -65.2×FY 2019: -29.7×FY 2020: 0.1×FY 2021: -4.7×FY 2022: -0.4×FY 2023: -0.1×FY 2024: -0.3×FY 2025: -5.0×
FY 2018 5y median -0.4× FY 2025
EV/Sales 2.9×
FY 2018: 33936×FY 2019: 1008×FY 2020: 0.0×FY 2021: 109×FY 2022: 2.2×FY 2023: 0.5×FY 2024: 1.0×FY 2025: 2.9×
FY 2018 5y median 2.2× FY 2025
FCF Yield -7.5%
FY 2018: -2.0%FY 2019: -5.1%FY 2020: -15.7%FY 2021: -12.6%FY 2022: -43.1%FY 2023: -52.9%FY 2024: -71.3%FY 2025: -7.5%
FY 2018 5y median -43.1% FY 2025

Profitability

Gross Margin 43.0%
FY 2018: 100.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 29.4%FY 2022: 40.3%FY 2023: 50.7%FY 2024: 48.9%FY 2025: 43.0%
FY 2018 5y median 43.0% FY 2025
Operating Margin -87.5%
FY 2018: -52200.9%FY 2019: -3711.8%FY 2020: 0.0%FY 2021: -2464.8%FY 2022: -587.4%FY 2023: -454.2%FY 2024: -290.3%FY 2025: -87.5%
FY 2018 5y median -454.2% FY 2025
Net Margin -195.8%
FY 2018: -126798.1%FY 2019: -11549.5%FY 2020: 0.0%FY 2021: -2280.5%FY 2022: -580.7%FY 2023: -441.7%FY 2024: -373.3%FY 2025: -195.8%
FY 2018 5y median -441.7% FY 2025
ROE -97.2%
FY 2018: 87.0%FY 2019: 67.2%FY 2020: -48.5%FY 2021: -25.2%FY 2022: -35.9%FY 2023: -45.6%FY 2024: -50.5%FY 2025: -97.2%
FY 2018 5y median -45.6% FY 2025
ROIC -29.5%
FY 2018: -70.7%FY 2019: -40.0%FY 2020: -12.4%FY 2021: -25.8%FY 2022: -32.5%FY 2023: -39.4%FY 2024: -28.9%FY 2025: -29.5%
FY 2018 5y median -29.5% FY 2025
ROA -54.8%
FY 2018: -80.0%FY 2019: -94.7%FY 2020: -44.0%FY 2021: -22.5%FY 2022: -30.3%FY 2023: -35.8%FY 2024: -35.1%FY 2025: -54.8%
FY 2018 5y median -35.1% FY 2025

Growth (YoY)

Revenue 74.7%
FY 2018: 0.0%FY 2019: 2450.2%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 373.1%FY 2023: 19.3%FY 2024: -9.0%FY 2025: 74.7%
FY 2018 FY 2025
Operating Income 47.4%
FY 2018: 0.0%FY 2019: -81.3%FY 2020: -116.6%FY 2021: -72.2%FY 2022: -12.8%FY 2023: 7.7%FY 2024: 41.8%FY 2025: 47.4%
FY 2018 FY 2025
EPS (diluted) 7.0%
FY 2018: 0.0%FY 2019: 47.5%FY 2020: -473.2%FY 2021: 86.0%FY 2022: -17.0%FY 2023: 9.2%FY 2024: 23.5%FY 2025: 7.0%
FY 2018 FY 2025
Free Cash Flow 77.5%
FY 2018: 0.0%FY 2019: -93.4%FY 2020: -32.4%FY 2021: -64.6%FY 2022: 3.3%FY 2023: 32.7%FY 2024: 15.5%FY 2025: 77.5%
FY 2018 FY 2025

Financial Health

Current Ratio 1.4×
FY 2018: 0.8×FY 2019: 2.1×FY 2020: 11.2×FY 2021: 9.5×FY 2022: 4.8×FY 2023: 4.0×FY 2024: 1.7×FY 2025: 1.4×
FY 2018 5y median 4.0× FY 2025
Quick Ratio 1.3×
FY 2018: 0.8×FY 2019: 2.1×FY 2020: 11.2×FY 2021: 9.4×FY 2022: 4.6×FY 2023: 3.9×FY 2024: 1.7×FY 2025: 1.3×
FY 2018 5y median 3.9× FY 2025
Debt / Equity 0.5×
FY 2018: -0.2×FY 2019: -0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.4×FY 2025: 0.5×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 1.5×
FY 2018: 0.7×FY 2019: 1.0×FY 2020: 5.6×FY 2021: 2.3×FY 2022: 1.5×FY 2023: 1.0×FY 2024: 0.7×FY 2025: 1.5×
FY 2018 5y median 1.5× FY 2025
Interest Coverage -21.7×
FY 2018: -61.5×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -282×FY 2022: -126×FY 2023: -63.6×FY 2024: -37.6×FY 2025: -21.7×
FY 2018 5y median -63.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31